Clinical features at baseline based on case record reviews, discharge letters, and interviews
| Control group (%) | Non-HF heart disease (%) | GP-HF (%) | Hospital-HF (%) | |
|---|---|---|---|---|
| ACE, angiotensin converting enzyme; ASA, acetylsalicylic acid; GP, general practice; non-HF, patients with evidence of heart disease but not of heart failure; MI, myocardial infarction. | ||||
| *Treatment in the control group was not systematically recorded. | ||||
| Number | 672 | 242 | 77 | 38 |
| Demographic | ||||
| Men | 39 | 35 | 34 | 68 |
| Women | 61 | 65 | 66 | 32 |
| Mean (SD) age (years) | 74.1 (10.9) | 74.4 (10.7) | 75.8 (11.9) | 76.7 (10.8) |
| Reaction to questionnaire | ||||
| Nursing home residency | 15 | 10 | 13 | 11 |
| Non-responder | 15 | 10 | 9 | 11 |
| Responder | 70 | 80 | 78 | 79 |
| Recorded heart disease in GP case note | ||||
| Previous MI | 0 | 12 | 6 | 53 |
| Angina pectoris | 0 | 22 | 10 | 45 |
| Atrial fibrillation | 0 | 24 | 27 | 37 |
| Hypertensive heart disease | 0 | 46 | 47 | 32 |
| Diabetic heart disease | 0 | 13 | 12 | 11 |
| Recorded treatment from GP case notes* | ||||
| Diuretic agent | 2.2 | 26 | 47 | 55 |
| ASA | 0.3 | 11 | 10 | 37 |
| Digoxin | 0.3 | 24 | 49 | 50 |
| β or calcium antagonist | 0.9 | 17 | 9 | 18 |
| ACE inhibitor | 0.3 | 1.7 | 8 | 16 |
| Nitrate agent | 0 | 6.2 | 3 | 21 |